Ibex: FDA clearance affirms Ibex’s position as a global leader in AI-powered cancer diagnostics February 10, 2025 08:05 AM Eastern Standard Time BOSTON--(BUSINESS WIRE)--Ibex Medical Analytics (Ibex), the leader in...

BOSTON--(BUSINESS WIRE)--Modella AI, a pioneer in generative and agentic artificial intelligence for biomedicine, is proud to announce that its cutting-edge generative AI co-pilot, PathChat DX, has been granted Breakthrough Device...

From Deciphex on LinkedIn: We’re excited to announce that Gary Roche, our Business Development Manager, will be attending the 14th Global Summit on Regulatory Science, hosted by the FDA in Little Rock, Arkansas. Gary will be there to...

From the Dark Daily: Infection control teams and clinical laboratory managers may want to look at this new product designed to improve the diagnosis and treatment of sepsis Accurate and fast diagnosis of sepsis for patients arriving in...

Proscia: Key regulatory milestone advances company’s mission to perfect cancer diagnosis. PHILADELPHIA – February 12, 2024 – Proscia®, a leading provider of digital and computational pathology solutions, has received 510(k) clearance...

Lunit INSIGHT DBT receives FDA 510(k) clearance, poised to enter the world's largest DBT market SEOUL, South Korea, Nov. 14, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics...